ONCODEcipher Breast & Ovarian Liquid Premium NGS panel
Product Description:
Non-invasive cell free circulating tumor DNA (ctDNA) panel that delivers information on a variety of treatment/prognosis informative mutations in the genes which are known to play a role in solid tumors using only the blood of the patients.
Highlighted Genes -- BRCA1 & BRCA2, ESR1, PIK3CA, TP53, MLH1, MSH2, MSH6 and etc.
Technique:
Next Generation Sequencing (NGS)
Test Methodology:
Cell free DNA extracted from plasma is subjected to amplification-based library preparation and massively parallel sequencing. Sequencing analysis is performed using commercial bioinformatics pipelines and annotation is done using proprietary and public databases.
Specimen Requirements:
- 15ml Blood in cfDNA tubes (2 tubes)
Turn Around Time:
10-15 Working Days
3-4 weeks (For germline results)
Shipment Requirement:
Keep specimens at room temperature. DO NOT ship on ice or dry ice or expose to direct sunlight.